Mehmet Erdem Toker Selected Research

Therapeutics

2/2012

Hybrid coronary revascularization for the treatment of left main coronary artery disease in high-risk patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mehmet Erdem Toker Research Topics

Disease

2	Hypertension (High Blood Pressure) 05/2012 - 02/2009
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 01/2013
1	Coronary Stenosis (Coronary Artery Stenosis) 02/2012
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 02/2012
1	Hemorrhage 06/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2009
1	Peripheral Arterial Disease 02/2009
1	Chronic Renal Insufficiency 02/2009
1	False Aneurysm (Pseudoaneurysm) 01/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2005
1	Ventricular Septal Rupture 01/2005
1	Atrial Heart Septal Defects (Atrial Septal Defect) 06/2003
1	Left Ventricular Dysfunction 01/2002
1	Death (Near-Death Experience) 01/2002

Therapy/Procedure

3	Sutures (Suture) 01/2007 - 06/2003
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2013 - 09/2005
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2009 - 01/2002
1	Heart Transplantation (Grafting, Heart) 05/2012
1	Therapeutics 02/2012
1	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 02/2012
1	Percutaneous Coronary Intervention 02/2012
1	Reoperation 06/2010
1	Carotid Endarterectomy 09/2005
1	Extracorporeal Circulation 01/2002